Azitromicina en Bronquiectasias.Estudio BAT

Among adults with non-CF bronchiectasis, the daily use of azithromycin for 12 months compared with placebo resulted in a lower rate of infectious exacerbations. This could result in better quality of life and might influence survival, although effects on antibiotic resistance need to be considered.

En JAMA

Outcomes of Pseudomonas eradication therapy in patients with non-cystic fibrosis bronchiectasis

RedBOX